Skip to main content
. Author manuscript; available in PMC: 2010 Mar 1.
Published in final edited form as: Arthritis Rheum. 2009 Mar;60(3):801–812. doi: 10.1002/art.24352

Table 1. ΔCT Values (CT[target] - CT[GAPDH]).

Vector Treatment ACP COL II COL X MMP-13
Ad.GFP -IL-1, -TGF 7.9 (1.5) 11.2 (0.2) 9.2 (3.2) 3.9 (3.6)
Ad.GFP -IL-1, +TGF 0.1 (0.3) -1.5 (0.80) -0.5 (1.0) 2.8 (1.4)
Ad.GFP +IL-1, -TGF 10.0 (3.5) 10.3 (4.1) 10.1 (3.9) 2.4 (2.5)
Ad.GFP +IL-1, +TGF 6.3 (1.8) 5.7 (2.7) 4.3 (0.6) -2.7 (2.4)
Ad.srIκB -IL-1, -TGF 7.0 (3.2) 9.3 (4.2) 7.8 (2.4) 6.1 (3.2)
Ad.srIκB -IL-1, +TGF 0.6 (0.8) -0.7 (1.7) 0.5 (2.5) 3.6 (1.6)
Ad.srIκB +IL-1, -TGF 9.7 (3.7) 11.7 (5.3) 12.8 (5.6) 3.8 (3.7)
Ad.srIκB +IL-1, +TGF 2.2 (2.3) 0.8 (3.8) 3.9 (4.4) 0.3 (4.7)
p-values (Student’s t-test)
Ad.GFP +TGF, -IL-1 vs. +IL-1 0.004 0.012 0.002 0.024
Ad.srIκB +TGF, -IL-1 vs. +IL-1 0.315 0.561 0.311 0.303

ΔCT values presented as Mean (Standard Deviation)